A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
about
Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin TetramerInvolvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its TreatmentManagement of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathyEarly intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathyLong-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.Iatrogenic amyloid polyneuropathy after domino liver transplantation.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran.Transthyretin deposition promotes progression of osteoarthritis.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning.
P2860
Q28551432-2314DCA4-5661-4E65-88A9-F753CB1014F3Q36151383-DA72E601-B62B-4B60-BFA2-7938AD69C28BQ37420577-FD927814-3B0A-436D-B0EA-0010134454EAQ37713229-0D7E5AE3-5506-49A7-8410-72B767971538Q38652127-74F0DD88-3E96-4724-9125-E7087C84B105Q38720600-338F4E9D-203E-402B-BCBE-E3CA2ABC4901Q38844927-B553BCE9-9354-4C5E-B2AE-5640A6831C46Q39143674-D7775141-EF30-4208-8BC4-F94BCC01FACAQ41106725-74944A01-E600-420E-BADB-F47D811CAC86Q47106501-3BEC9153-7F39-4AE2-8D33-7C509C4CFD56Q47112070-77E1E9D8-A897-464F-A428-D3C3F607A273Q47561760-C6BC612A-58A9-4EEE-AB56-A2FA0E78B586Q55310742-F51A68E3-8A4F-4C0D-A1A6-E023C07043D3
P2860
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@ast
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@en
type
label
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@ast
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@en
prefLabel
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@ast
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@en
P2860
P1476
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.
@en
P2093
Merril D Benson
Márcia Waddington Cruz
P2860
P2888
P356
10.1007/S40120-015-0031-3
P407
P577
2015-08-15T00:00:00Z